{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:16:51Z","timestamp":1772165811266,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T00:00:00Z","timestamp":1681948800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T00:00:00Z","timestamp":1681948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Methamphetamine is an addictive drug with various effects on the neurotransmitters in the central nervous system. Methamphetamine-induced encephalopathy in the absence of hyperammonemia presents a unique challenge in a clinical setting. Previously published cases of methamphetamine-induced encephalopathy suggested that methamphetamine-induced hepatotoxicity and subsequent hyperammonemia may be the cause of encephalopathy. However, the literature is limited on methamphetamine-induced encephalopathy without hyperammonemia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case<\/jats:title>\n                    <jats:p>This case presents a disoriented patient with methamphetamine use disorder in acute toxicity, unable to ambulate independently, and poorly responsive to verbal stimuli. The patient was found to have normal ammonia levels.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>This patient\u2019s presentation and laboratory findings, namely normal ammonia levels, suggest a different pathophysiological pathway for methamphetamine-induced encephalopathy. One potential pathway is through the direct action of methamphetamine on the central nervous system through acute disruption of neurotransmitter signaling and disruption of the blood-brain barrier.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Further research should be conducted into the prevalence and pathophysiology of methamphetamine-induced encephalopathy in the absence of hyperammonemia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key Points<\/jats:title>\n                    <jats:p>Methamphetamine-induced encephalopathy (MIE) in the absence of hyperammonemia presents a unique challenge in a clinical setting.<\/jats:p>\n                    <jats:p>Previously published cases of MIE suggest that methamphetamine-induced hepatotoxicity and subsequent hyperammonemia may be the cause of encephalopathy.<\/jats:p>\n                    <jats:p>Further research should be conducted into the prevalence and pathophysiology of MIE in the absence of hyperammonemia.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12888-023-04764-2","type":"journal-article","created":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T14:16:10Z","timestamp":1682000170000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Methamphetamine-induced encephalopathy in the absence of hyperammonemia"],"prefix":"10.1186","volume":"23","author":[{"given":"Jessica M","family":"Rabbany","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaylee","family":"Fitzgerald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jade","family":"Bowman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fanglong","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael M.","family":"Neeki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,4,20]]},"reference":[{"key":"4764_CR1","unstructured":"National Institute on Drug Abuse. Methamphetamine Drug Facts. 2019 [cited 2022 May 3]; Available from: https:\/\/nida.nih.gov\/publications\/drugfacts\/methamphetamine."},{"issue":"12","key":"4764_CR2","doi-asserted-by":"publisher","first-page":"317","DOI":"10.15585\/mmwr.mm6912a1","volume":"69","author":"CM Jones","year":"2020","unstructured":"Jones CM, Compton WM, Mustaquim D. Patterns and characteristics of methamphetamine use among adults\u2014United States, 2015\u20132018. Morb Mortal Wkly Rep. 2020;69(12):317.","journal-title":"Morb Mortal Wkly Rep"},{"key":"4764_CR3","unstructured":"National Institute on Drug Abuse. What is the scope of methamphetamine use in the United States? [cited 2022 May 3]; Available from: https:\/\/nida.nih.gov\/publications\/research-reports\/methamphetamine\/what-scope-methamphetamine-misuse-in-united-states."},{"issue":"18","key":"4764_CR4","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1212\/WNL.0000000000011850","volume":"96","author":"DI Katz","year":"2021","unstructured":"Katz DI, Bernick C, Dodick DW, et al. National Institute of Neurological Disorders and Stroke consensus diagnostic criteria for traumatic encephalopathy syndrome. Neurology. 2021;96(18):848\u201363.","journal-title":"Neurology"},{"key":"4764_CR5","unstructured":"Mandiga P, Foris LA, Bollu PC. Hepatic encephalopathy. StatPearls [Internet]; 2021."},{"key":"4764_CR6","volume-title":"Basic Neurochemistry: Molecular, Cellular and Medical Aspects","author":"RF Butterworth","year":"1999","unstructured":"Butterworth RF. Basic Neurochemistry: Molecular, Cellular and Medical Aspects. Philadelphia: Lippincott-Raven; 1999."},{"issue":"1","key":"4764_CR7","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s40265-018-1018-z","volume":"79","author":"K Weissenborn","year":"2019","unstructured":"Weissenborn K. Hepatic encephalopathy: definition, clinical grading and diagnostic principles. Drugs. 2019;79(1):5\u20139.","journal-title":"Drugs"},{"issue":"1","key":"4764_CR8","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1097\/JCP.0000000000001464","volume":"42","author":"NA Jannatabadi","year":"2022","unstructured":"Jannatabadi NA, Bordbar MRF, Etemad L, Eizadi-Mood N, Jomehpour H, Moshiri M. Methamphetamine-Associated Hyperammonemic Encephalopathy. J Clin Psychopharmacol. 2022;42(1):92\u20134.","journal-title":"J Clin Psychopharmacol"},{"key":"4764_CR9","doi-asserted-by":"publisher","unstructured":"John R, Richards, Valeria F, Farias CS, Clingan. \u201cAssociation of Leukocytosis with Amphetamine and Cocaine Use\u201d, The Scientific World Journal, vol. 2014, Article ID 207651, 7 pages, 2014. https:\/\/doi.org\/10.1155\/2014\/207651","DOI":"10.1155\/2014\/207651"},{"issue":"2","key":"4764_CR10","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1080\/00325481.1983.11697759","volume":"73","author":"H Larry","year":"1983","unstructured":"Larry H, Goldberg. Amphetamines and leukocytosis. Postgrad Med. 1983;73(2):113\u201323. https:\/\/doi.org\/10.1080\/00325481.1983.11697759.","journal-title":"Postgrad Med"},{"issue":"3","key":"4764_CR11","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.psym.2015.12.011","volume":"57","author":"M Lama","year":"2016","unstructured":"Lama M, Shannon S, Davin Q. Methamphetamine intoxication encephalopathy associated with hyperammonemia. Psychosomatics. 2016;57(3):325\u20139.","journal-title":"Psychosomatics"},{"issue":"38","key":"4764_CR12","doi-asserted-by":"publisher","first-page":"13155","DOI":"10.1523\/JNEUROSCI.2530-12.2012","volume":"32","author":"LE Halpin","year":"2012","unstructured":"Halpin LE, Yamamoto BK. Peripheral ammonia as a mediator of methamphetamine neurotoxicity. J Neurosci. 2012;32(38):13155\u201363.","journal-title":"J Neurosci"},{"issue":"2","key":"4764_CR13","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/S0306-4522(03)00476-7","volume":"122","author":"T Guilarte","year":"2003","unstructured":"Guilarte T, Nihei M, McGlothan J, Howard A. Methamphetamine-induced deficits of brain monoaminergic neuronal markers: distal axotomy or neuronal plasticity. Neuroscience. 2003;122(2):499\u2013513.","journal-title":"Neuroscience"},{"issue":"2","key":"4764_CR14","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.nbd.2011.11.005","volume":"45","author":"S Ares-Santos","year":"2012","unstructured":"Ares-Santos S, Granado N, Oliva I, et al. Dopamine D1 receptor deletion strongly reduces neurotoxic effects of methamphetamine. Neurobiol Dis. 2012;45(2):810\u201320.","journal-title":"Neurobiol Dis"},{"issue":"3","key":"4764_CR15","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.nbd.2011.01.033","volume":"42","author":"N Granado","year":"2011","unstructured":"Granado N, Ares-Santos S, Oliva I, Martin ED, Colado MI, Moratalla R. Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA. Neurobiol Dis. 2011;42(3):391\u2013403.","journal-title":"Neurobiol Dis"},{"key":"4764_CR16","doi-asserted-by":"crossref","unstructured":"Seiden LS, Fischman MW, Schuster CR. Long-term methamphetamine induced changes in brain catecholamines in tolerant rhesus monkeys. Drug and alcohol dependence; 1976.","DOI":"10.1016\/0376-8716(76)90030-2"},{"issue":"7","key":"4764_CR17","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1002\/syn.20324","volume":"60","author":"JF Bowyer","year":"2006","unstructured":"Bowyer JF, Ali S. High doses of methamphetamine that cause disruption of the blood-brain barrier in limbic regions produce extensive neuronal degeneration in mouse hippocampus. Synapse. 2006;60(7):521\u201332.","journal-title":"Synapse"},{"issue":"5","key":"4764_CR18","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1111\/j.1460-9568.2007.05741.x","volume":"26","author":"EA Kiyatkin","year":"2007","unstructured":"Kiyatkin EA, Brown PL, Sharma HS. Brain edema and breakdown of the blood\u2013brain barrier during methamphetamine intoxication: critical role of brain hyperthermia. Eur J Neurosci. 2007;26(5):1242\u201353.","journal-title":"Eur J Neurosci"},{"key":"4764_CR19","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.brainres.2011.07.013","volume":"1411","author":"T Martins","year":"2011","unstructured":"Martins T, Baptista S, Gon\u00e7alves J, et al. Methamphetamine transiently increases the blood\u2013brain barrier permeability in the hippocampus: role of tight junction proteins and matrix metalloproteinase-9. Brain Res. 2011;1411:28\u201340.","journal-title":"Brain Res"},{"key":"4764_CR20","doi-asserted-by":"publisher","unstructured":"Bowyer JF, Ali S. High doses of methamphetamine that cause disruption of the blood-brain barrier in limbic regions produce extensive neuronal degeneration in mouse hippocampus. Synapse. 2006 Dec 1;60(7):521 \u2013 32. doi: https:\/\/doi.org\/10.1002\/syn.20324. PMID: 16952162.","DOI":"10.1002\/syn.20324"},{"key":"4764_CR21","doi-asserted-by":"publisher","unstructured":"Kiyatkin EA, Brown PL, Sharma HS. Brain edema and breakdown of the blood-brain barrier during methamphetamine intoxication: critical role of brain hyperthermia. Eur J Neurosci. 2007 Sep;26(5):1242-53. doi: https:\/\/doi.org\/10.1111\/j.1460-9568.2007.05741.x. PMID: 17767502.","DOI":"10.1111\/j.1460-9568.2007.05741.x"},{"issue":"1","key":"4764_CR22","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jchemneu.2008.08.002","volume":"37","author":"HS Sharma","year":"2009","unstructured":"Sharma HS, Kiyatkin EA. Rapid morphological brain abnormalities during acute methamphetamine intoxication in the rat: an experimental study using light and electron microscopy. J Chem Neuroanat. 2009;37(1):18\u201332. https:\/\/doi.org\/10.1016\/j.jchemneu.2008.08.002.","journal-title":"J Chem Neuroanat"},{"key":"4764_CR23","doi-asserted-by":"publisher","unstructured":"Salter, M. W., & Beggs, S. (2014). Sublime microglia: Expanding roles for the guardians of the CNS. Cell, 158(1), 15\u201324. https:\/\/doi.org\/10.1016\/j.cell.2014.06.008.","DOI":"10.1016\/j.cell.2014.06.008"},{"issue":"2","key":"4764_CR24","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/glia.21254","volume":"60","author":"AS Harms","year":"2012","unstructured":"Harms AS, Lee JK, Nguyen TA, et al. Regulation of microglia effector functions by tumor necrosis factor signaling. Glia. 2012;60(2):189\u2013202. https:\/\/doi.org\/10.1002\/glia.21254.","journal-title":"Glia"},{"issue":"1","key":"4764_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/jpet.104.070961","volume":"311","author":"DM Thomas","year":"2004","unstructured":"Thomas DM, Walker PD, Benjamins JA, Geddes TJ, Kuhn DM. Methamphetamine neurotoxicity in dopamine nerve endings of the striatum is associated with microglial activation. J Pharmacol Exp Ther. 2004;311(1):1\u20137. https:\/\/doi.org\/10.1124\/jpet.104.070961.","journal-title":"J Pharmacol Exp Ther"},{"issue":"22","key":"4764_CR26","doi-asserted-by":"publisher","first-page":"5756","DOI":"10.1523\/JNEUROSCI.1179-08.2008","volume":"28","author":"Y Sekine","year":"2008","unstructured":"Sekine Y, Ouchi Y, Sugihara G, et al. Methamphetamine causes microglial activation in the brains of human abusers. J Neurosci. 2008;28(22):5756\u201361. https:\/\/doi.org\/10.1523\/JNEUROSCI.1179-08.2008.","journal-title":"J Neurosci"},{"issue":"4","key":"4764_CR27","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1007\/s11064-021-03513-9","volume":"47","author":"S Shi","year":"2022","unstructured":"Shi S, Chen T, Zhao M. The crosstalk between neurons and Glia in Methamphetamine-Induced Neuroinflammation. Neurochem Res. 2022;47(4):872\u201384. https:\/\/doi.org\/10.1007\/s11064-021-03513-9.","journal-title":"Neurochem Res"},{"issue":"13","key":"4764_CR28","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1038\/s41386-021-01139-7","volume":"46","author":"T Canedo","year":"2021","unstructured":"Canedo T, Portugal CC, Socodato R, et al. Astrocyte-derived TNF and glutamate critically modulate microglia activation by methamphetamine. Neuropsychopharmacology. 2021;46(13):2358\u201370. https:\/\/doi.org\/10.1038\/s41386-021-01139-7.","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"4764_CR29","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.neulet.2003.08.015","volume":"352","author":"M Asanuma","year":"2003","unstructured":"Asanuma M, Tsuji T, Miyazaki I, Miyoshi K, Ogawa N. Methamphetamine-induced neurotoxicity in mouse brain is attenuated by ketoprofen, a non-steroidal anti-inflammatory drug. Neurosci Lett. 2003;352(1):13\u20136. https:\/\/doi.org\/10.1016\/j.neulet.2003.08.015.","journal-title":"Neurosci Lett"},{"issue":"1\u20132","key":"4764_CR30","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.brainres.2005.05.049","volume":"1050","author":"DM Thomas","year":"2005","unstructured":"Thomas DM, Kuhn DM. MK-801 and dextromethorphan block microglial activation and protect against methamphetamine-induced neurotoxicity. Brain Res. 2005;1050(1\u20132):190\u20138. https:\/\/doi.org\/10.1016\/j.brainres.2005.05.049.","journal-title":"Brain Res"},{"issue":"5","key":"4764_CR31","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.biopsych.2006.03.019","volume":"61","author":"K Hashimoto","year":"2007","unstructured":"Hashimoto K, Tsukada H, Nishiyama S, Fukumoto D, Kakiuchi T, Iyo M. Protective effects of minocycline on the reduction of dopamine transporters in the striatum after administration of methamphetamine: a positron emission tomography study in conscious monkeys. Biol Psychiatry. 2007;61(5):577\u201381. https:\/\/doi.org\/10.1016\/j.biopsych.2006.03.019.","journal-title":"Biol Psychiatry"},{"issue":"2","key":"4764_CR32","first-page":"65","volume":"11","author":"P Sariaslani","year":"2012","unstructured":"Sariaslani P, Ghanbari A, Ghanbari P. Multifocal inflammatory leukoencephalopathy induced by accidental consumption of levamisole: a case report. Iran J Neurol. 2012;11(2):65.","journal-title":"Iran J Neurol"},{"key":"4764_CR33","doi-asserted-by":"crossref","first-page":"232470961986826","DOI":"10.1177\/2324709619868266","volume":"7","author":"EC Mader Jr","year":"2019","unstructured":"Mader EC Jr, Ramos AB, Cruz RA, Branch LA. Full recovery from cocaine-induced toxic leukoencephalopathy: emphasizing the role of neuroinflammation and brain edema. J Investig Med High Impact Case Rep. 2019;7:2324709619868266.","journal-title":"J Investig Med High Impact Case Rep"},{"issue":"8","key":"4764_CR34","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1212\/WNL.53.8.1765","volume":"53","author":"A Kriegstein","year":"1999","unstructured":"Kriegstein A, Shungu D, Millar W, et al. Leukoencephalopathy and raised brain lactate from heroin vapor inhalation (\u201cchasing the dragon\u201d). Neurology. 1999;53(8):1765\u20135.","journal-title":"Neurology"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-023-04764-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-023-04764-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-023-04764-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T14:17:39Z","timestamp":1682000259000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-023-04764-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,20]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4764"],"URL":"https:\/\/doi.org\/10.1186\/s12888-023-04764-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2383385\/v1","asserted-by":"object"}]},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,20]]},"assertion":[{"value":"15 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Institutional Review Board at Arrowhead Regional Medical Center (ARMC) approved this study as exempt study with approval number 22\u201315. No patient identifier was included in this manuscript. This study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. Informed verbal consent was obtained from the patients with date and time. The consent form is available upon reasonable request.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and informed consent to participate"}},{"value":"Informed verbal consent was obtained from the patients with date and time. The consent form is available upon reasonable request.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent for publication"}},{"value":"All authors declared no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"276"}}